The gut microbiome regulates the clinical efficacy of sulfasalazine therapy for IBD-associated spondyloarthritis-Reference-Cited by-同舟云学术

The gut microbiome regulates the clinical efficacy of sulfasalazine therapy for IBD-associated spondyloarthritis

Published:2024-03 Issue:3 Volume:5 Page:101431
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Lima Svetlana F.,Pires Silvia,Rupert Amanda,Oguntunmibi Seun,Jin Wen-Bing,Marderstein Andrew,Funez-dePagnier Gabriela,Maldarelli Grace,Viladomiu Monica,Putzel Gregory,Yang Wei,Tran Nancy,Xiang Grace,Grier Alex,Guo Chun-Jun,Lukin Dana,Mandl Lisa A.,Scherl Ellen J.,Longman Randy S.

Funder

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Elsevier BV

Reference73 articles.

1. Ankylosing Spondylitis and Axial Spondyloarthritis in Patients With Long-term Inflammatory Bowel Disease: Results From 20 Years of Follow-up in the IBSEN Study;Ossum;J. Crohns Colitis,2018

2. Classifying Back Pain and Peripheral Joint Complaints in Inflammatory Bowel Disease Patients: A Prospective Longitudinal Follow-up Study;van Erp;J. Crohns Colitis,2016

3. The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study);Palm;Rheumatology,2001

4. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history;Orchard;Gut,1998

5. Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study;Ditisheim;Inflamm. Bowel Dis.,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxicity and therapeutic property of dioxopiperidin derivative SKT40 demonstrated in-vivo zebrafish model due to inflammatory bowel disease;Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology;2024-10

2. Marine Algae and Deriving Biomolecules for the Management of Inflammatory Bowel Diseases: Potential Clinical Therapeutics to Decrease Gut Inflammatory and Oxidative Stress Markers?;Marine Drugs;2024-07-25